| Description |
Confirmed Speakers For 2nd Annual Metabolic Diseases World Summit
Richard Ho, PhD
Head, Medical Informatics, Johnson & Johnson Pharmaceutical R&D
Peer Jacobson, PhD
Project Leader, Metabolic Disease Research, Abbott Laboratories
Ming Wang, PhD
Department of Metabolic Disorders, Amgen Inc.
David Erbe, PhD
Cardiovascular and Metabolic Diseases, Wyeth Research
Joseph S. Grimsby, Ph.D.
Sr. Research Leader, Metabolic Diseases, Hoffmann-La Roche
Linda Egger, PhD
Assoc Director, Scientific Liaison, External Scientific Affairs, Merck & Co., Inc.
Dr. Doug Greene
Vice President, Product Development, Sanofi Aventis
Te Yuan Kiu, MD
Pfizer, Inc.
Dan Einhorn
Head, Scripps Whittier Diabetes Institute
John Gerich, MD
Clinical Research Center, University of Rochester School of Medicine
Aaron Vinik, MD, PhD
Director of Research, Strelitz Diabetes Institutes, University of Eastern Virginia
Paresh Dandona, MD
Professor of Medicine, University of Buffalo
David Bell, MD
Endocrinologist, University of Alabama at Birmingham School of Medicine
Grant Barish, MD
Howard Hughes Medical Institute and Gene Expression Laboratory, The Salk Institute for Biological Studies
Bernice Welles, MD, MBA
Vice President, Development, DiObex
Tian-Li Yue, PhD
Manager, Investigative & Cardiac Biology, GlaxoSmithKline
Scott Braunstein
JP Morgan
Lois Jovanovic
Sansum Diabetes Research Institute
Wick Johnson, Ph.D.
Director, Licensing & Development, Pfizer Inc
John P. Mayer, PhD
Eli Lilly & Co.
Jean Claude Desmangles
Creighton University
Rolf Thierringer
Department of Cardiovascular Diseases, Merck Research Laboratories
Robert Mashal
President & CEO, Alinea Pharmaceuticals
Joel G Ray, MD MSc FRCPC
Assist Prof & Clinician Scientist, Dept of Med, Div of Endocrinology and Metabolism, University of Toronto
John Holcombe, MD
Medical Fellow, US Diabetes Care, Eli Lilly & Co.
CONFERENCE CHAIRPERSON
Marc Rendell, MD
Creighton University
Lori Gowen Morton
Staff Scientist, Regeneron Pharmaceuticals
Ronald E. Law, PhD, JD
Director, Medical and Scientific Product Evaluation, Takeda Pharmaceuticals North America
John Rodzvilla, MD
Auxilium Pharmaceuticals
Sanjay Bhanot, MD, PhD
Vice President, Metabolic Diseases Research & Development, Isis Pharmaceuticals
Harold Wright
Director, Biology, CytRx Corp
Daniel J. Wilson, MD
Director, Regional Medical Research Specialist Cardiovascular - Midwest, Pfizer Inc.
|
|
